Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,380 public trials 841 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

NCT04585074

Conditions
Benign Breast Disease, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Kosin University Gospel Hospital Busan, South Korea
  • Chungnam National University Sejong Hospital Sejong, Chungcheongnam-do, South Korea
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
  • Wonju Severance Christian hospital Wŏnju, Gangwon-do, South Korea
View all 18 locations
View Trial Details
Active, Not Recruiting

PEP and O-PEP Device for Nebulization in Cystic Fibrosis

NCT06964074

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • National Tuberculosis and Lung Diseases Research Institute Rabka-Zdrój, Malopolska, Poland
  • National Institute Tuberculosis and Lung Diesases Rabka-Zdrój, Małopolska, Poland
View Trial Details
Active, Not Recruiting

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

NCT02912949

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • University of California Irvine Irvine, California, United States
  • Stanford University Palo Alto, California, United States
View all 64 locations
View Trial Details

Related conditions